Invuity, a Bay Area medtech that builds surgical tools to help illuminate a patient’s innards during an operation, just raised $20 million in equity. The new dollars will help Invuity up ...

Philip Sawyer resigned as President and CEO of Invuity, a medical technology company focused on minimal access surgery. Scott Flora will serve as interim President and CEO. Here are three insights. 1.

SAN FRANCISCO, CA--(Marketwired - Nov 7, 2017) - Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on minimal access surgery, today reported financial results for the quarter ...

Invuity (IVTY) just came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.61 per share a year ago. These figures are ...

Stryker Corp. is purchasing surgical device maker Invuity for $190 million. 1. Stryker agreed to acquire all of Invuity’s outstanding shares for $7.40 per share, for a total of about $190 million.

While small-cap stocks, such as Invuity Inc (NASDAQ:IVTY) with its market cap of US$86.55M, are popular for their explosive growth, investors should also be aware of their balance sheet to judge ...

SAN FRANCISCO, June 14, 2012 /PRNewswire/ -- Invuity, a leading developer of state-of-the-art surgical visualization and illumination technology, has raised a $25 million Series D round of financing ...

Invuity, which sells illumination devices used in minimally invasive and minimal access surgeries, raised $48 million by offering 4 million shares at $12, as expected. The company had originally ...

Invuity is counting on the fact that open surgeries, in which a sizable incision is made and the operation is illuminated only from above, are on their way out. Instead, the company is targeting the ...

Advances in minimally-invasive surgery have made for smaller and smaller incisions, thereby reducing the risk of infection and greatly improving patient recovery times. Yet, operating in tiny spaces ...